Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Apr 2026 for Opus Genetics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Sean Ainsworth: trading record in brief
All filings by Sean Ainsworth on record concern Opus Genetics, Inc. We count 7 filings; the first trade dates from 19 October 2022 and the latest from 20 April 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 22 April 2026 came the latest disclosure, a share grant in Opus Genetics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sean Ainsworth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
24,367 shares0Common StockSEC:0000905148-26-001781:0
42,507 sharesCommon StockSEC:0000905148-26-000027:0
86,956 shares@ US$1.15100.0% of flowCommon StockSEC:0000905148-25-003151:0
79,504 shares0Common StockSEC:0000905148-25-001424:0
41,143 shares0Common StockSEC:0000905148-24-001709:0
10,976 shares0Common StockSEC:0001140361-23-029024:0
1,574 shares@ US$0.0001100.0% of flowCommon StockSEC:0001140361-22-037954:0
7 of 7 declarations
